These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8481545)
41. The effect of diabetic control on diabetic retinopathy. Kohner EM Eye (Lond); 1993; 7 ( Pt 2)():309-11. PubMed ID: 7607352 [TBL] [Abstract][Full Text] [Related]
42. Hypopituitarism stabilizes the renal and retinal complications of diabetes mellitus. Plumb M; Nath K; Seaquist ER Am J Nephrol; 1992; 12(4):265-7. PubMed ID: 1481875 [TBL] [Abstract][Full Text] [Related]
44. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem? Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569 [TBL] [Abstract][Full Text] [Related]
45. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in Type 2 diabetes mellitus. Fujisawa T; Ikegami H; Yamato E; Kawaguchi Y; Ueda H; Shintani M; Nojima K; Kawabata Y; Ono M; Nishino T; Noso S; Yamada K; Babaya N; Okamoto N; Ohguro N; Fukuda M; Ogihara T Diabet Med; 1999 Jun; 16(6):522-6. PubMed ID: 10391402 [TBL] [Abstract][Full Text] [Related]
46. Association of cigarette smoking with diabetic retinopathy. Moss SE; Klein R; Klein BE Diabetes Care; 1991 Feb; 14(2):119-26. PubMed ID: 2060413 [TBL] [Abstract][Full Text] [Related]
47. Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus. Kirkegaard C; Nørgaard K; Snorgaard O; Bek T; Larsen M; Lund-Andersen H Acta Endocrinol (Copenh); 1990 Jun; 122(6):766-72. PubMed ID: 2197845 [TBL] [Abstract][Full Text] [Related]
48. Somatomedin-C (SM-C). Study in diabetic patients with and without retinopathy. Nardelli GM; Guastamacchia E; Di Paolo S; Balice A; Rosco M; Santoro G; Lollino G; Giorgino R Acta Diabetol Lat; 1989; 26(3):217-24. PubMed ID: 2694716 [TBL] [Abstract][Full Text] [Related]
49. Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Boehm BO; Schilling S; Rosinger S; Lang GE; Lang GK; Kientsch-Engel R; Stahl P Diabetologia; 2004 Aug; 47(8):1376-9. PubMed ID: 15258735 [TBL] [Abstract][Full Text] [Related]
51. Rationale for inhibition of growth hormone secretion in the management of the diabetic patient. Gerich JE Scand J Gastroenterol Suppl; 1986; 119():154-7. PubMed ID: 2876500 [TBL] [Abstract][Full Text] [Related]
52. [Clinical value of urinary excretion of N-acetyl-beta-glucosaminidase in diabetic retinopathy]. Garbín Fuentes I ; Pérez Blanco FJ ; Pérez Chica G ; Moreno Terribas G ; Rodríguez Cuartero A ; Avilés Puigvert M Arch Soc Esp Oftalmol; 2000 Dec; 75(12):791-5. PubMed ID: 11151274 [TBL] [Abstract][Full Text] [Related]
53. Evolution and natural history of diabetic retinopathy during pregnancy. Srivatsa LP Metab Pediatr Syst Ophthalmol (1985); 1994; 17(1-4):19-28. PubMed ID: 8719281 [TBL] [Abstract][Full Text] [Related]
54. Urinary growth hormone excretion during puberty in type 1 (insulin-dependent) diabetes mellitus. Hourd P; Edge JA; Dunger DB; Dalton N; Edwards R Diabet Med; 1991 Apr; 8(3):237-42. PubMed ID: 1828739 [TBL] [Abstract][Full Text] [Related]
55. Does oxidant stress play a role in diabetic retinopathy? Rema M; Mohan V; Bhaskar A; Shanmugasundaram KR Indian J Ophthalmol; 1995 Mar; 43(1):17-21. PubMed ID: 8522364 [TBL] [Abstract][Full Text] [Related]
56. Development of diabetic retinopathy and its associated risk factors in type 2 diabetic patients in Osaka district, Japan: a long-term prospective study. Sasaki A; Horiuchi N; Hasewgawa K; Uehara M Diabetes Res Clin Pract; 1990; 10(3):257-63. PubMed ID: 2073873 [TBL] [Abstract][Full Text] [Related]
57. Proliferative diabetic retinopathy is associated with microalbuminuria in patients with type 2 diabetes. Boelter MC; Gross JL; Canani LH; Costa LA; Lisboa HR; Três GS; Lavinsky J; Azevedo MJ Braz J Med Biol Res; 2006 Aug; 39(8):1033-9. PubMed ID: 16906278 [TBL] [Abstract][Full Text] [Related]
58. Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Ballard DJ; Melton LJ; Dwyer MS; Trautmann JC; Chu CP; O'Fallon WM; Palumbo PJ Diabetes Care; 1986; 9(4):334-42. PubMed ID: 3743309 [TBL] [Abstract][Full Text] [Related]
59. [Clinical significance of urinary growth hormone in the diagnosis of diabetes mellitus]. Fushimi H; Inoue T; Kameyama M Nihon Rinsho; 1990 Dec; 48 Suppl():498-504. PubMed ID: 2086927 [No Abstract] [Full Text] [Related]
60. Elevated serum levels of soluble vascular cell adhesion molecule-1 in NIDDM patients with proliferative diabetic retinopathy. Yoshizawa M; Nagai Y; Ohsawa K; Ohta M; Yamashita H; Hisada A; Miyamoto I; Miura K; Takamura T; Kobayashi K Diabetes Res Clin Pract; 1998 Oct; 42(1):65-70. PubMed ID: 9884035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]